Imaginostics is a health tech company developing a quantitative vascular MRI platform and AI-powered biomarker engine that transforms standard MRI scanners into precision diagnostic instruments — no new hardware required. Our technology generates something conventional MRI cannot: individual-patient maps of microvascular density, blood-brain barrier permeability, and vessel structure, from a single scan on existing MRI systems. These quantitative vascular biomarkers provide valuable new insights into brain cancer, Alzheimer's disease, and neurodegeneration, which can lead to better treatments in the future. FDA Breakthrough Device Designation | Siemens Healthineers Non-Exclusive Partnership | NIH-funded | ADDF-backed
| Website | http://imaginostics.com/ |
| Employees | 5 (4 on RocketReach) |
| Founded | 2018 |
| Address | 6555 Sanger Rd Suite 100, Orlando, Florida 32827, US |
| Phone | +1 617-316-3270 |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Hospitals and Health Care |
| Keywords | Advanced Imaging, Vascular Imaging, Breakthrough Technology, Mri Technology, Innovative Imaging, Medical Imaging, High Resolution Imaging, Healthcare Technology, Quantitative Imaging, Imaging Solutions, Medical Devices, Diagnostic Imaging, Imaging Systems, Diagnostic Tools, Precision Imaging, Vascular Health |
| Competitors | Tempus Labs, Inc., Exact Sciences, Guardant Health, GRAIL, NeoGenomics Laboratories, Freenome, PathAI, Quantgene, OncoOne, thryve (pty) ltd +43 more (view full list) |
Looking for a particular Imaginostics employee's phone or email?
Valerie Gharagouzloo is the CEO of Imaginostics.
4 people are employed at Imaginostics.
Imaginostics is based in Orlando, Florida.